Swiss drugmaker Roche has unveiled plans to invest $50 billion in pharmaceuticals and diagnostics in the United States over the next five years. This move comes as the company aims to mitigate the impact of tariffs and create approximately 12,000 new jobs. Roche has selected Indiana for a new manufacturing plant and will expand its research facilities across the country. The initiative is part of a broader trend among drug companies to enhance U.S. production capabilities and counteract tariff threats.